相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh et al.
HEPATOLOGY (2020)
Review article: new therapeutic interventions for advanced hepatocellular carcinoma
Saroja Bangaru et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Teng-Yu Lee et al.
JAMA INTERNAL MEDICINE (2019)
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
Fasiha Kanwal et al.
GASTROENTEROLOGY (2019)
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
Tracey G. Simon et al.
ANNALS OF INTERNAL MEDICINE (2019)
Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms
Ali Fatehi Hassanabad
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
David E. Kaplan et al.
GASTROENTEROLOGY (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Potential molecular targets of statins in the prevention of hepatocarcinogenesis
Ezequiel Ridruejo et al.
ANNALS OF HEPATOLOGY (2018)
Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma
Ibrahim El Sayed et al.
LIFE SCIENCES (2018)
The impact of antiviral therapy on hepatocellular carcinoma epidemiology
Massimo Colombo et al.
HEPATIC ONCOLOGY (2018)
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
Gyuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Statins Decrease the Risk of Decompensation in Hepatitis B Virus- and Hepatitis C Virus-Related Cirrhosis: A Population-Based Study
Fu-Ming Chang et al.
HEPATOLOGY (2017)
Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
Zubing Mei et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells
Sin-Ting Wang et al.
CELL DEATH & DISEASE (2017)
Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
Chang Seok Bang et al.
BMC GASTROENTEROLOGY (2017)
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis
Arpan Mohanty et al.
GASTROENTEROLOGY (2016)
Atorvastatin and Fluvastatin Are Associated With Dose-Dependent Reductions in Cirrhosis and Hepatocellular Carcinoma, Among Patients With Hepatitis C Virus: Results From ERCHIVES
Tracey G. Simon et al.
HEPATOLOGY (2016)
Statins for Prevention of Cardiovascular Disease in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force
Roger Chou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis
Christoph Roderburg et al.
VISCERAL MEDICINE (2016)
Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
Adeel A. Butt et al.
HEPATOLOGY (2015)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Cancer Risk in HBV Patients With Statin and Metformin Use A Population-Based Cohort Study
Chang-I. Chen et al.
MEDICINE (2015)
Statins are potential anticancerous agents (Review)
Abdullah K. Altwairgi
ONCOLOGY REPORTS (2015)
Hepatitis B virus infection and metabolic syndrome: Fact or fiction?
Chia-Chi Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Hui Zhang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression
Janine Kah et al.
ONCOLOGY REPORTS (2012)
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Zhongwei Cao et al.
CANCER RESEARCH (2011)
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma
Won Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation
Nikolaos A. Patsopoulos et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis
H Kuper et al.
HEPATOLOGY (2001)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
